Nadezhda Vasilyeva: Shifting the Boundaries of Acute Ischemic Stroke Management
Nadezhda Vasilyeva, Neurologist, shared a post on LinkedIn:
“The boundaries of acute ischemic stroke management are shifting: the 2026 AHA/ASA guidance allows tenecteplase 0.25 mg/kg as an alternative to alteplase within 4.5 hours or less; concurrently, trials (e.g. HOPE) are investigating selective thrombolysis expansion to 4.5-24 hours using perfusion-based selection.
Antithrombotic management after reperfusion remains a trade-off: ATIS‑NVAF data showed increased bleeding without clear clinical benefit when combining anticoagulants and antiplatelets.
The emergence of Factor XIa inhibitors (e.g. asundexian; Phase III OCEANIC‑STROKE) shows reduced recurrence with an acceptable bleeding profile – potentially addressing a key neuro-safety dilemma.
As a clinician with 5+ years in neurology, I translate this bedside experience into rigorous ICH‑GCP safety monitoring.
Colleagues in research teams – how are you adapting monitoring systems for extended thrombolysis windows and new antithrombotic combinations?”
Stay updated with Hemostasis Today.
-
Sep 1, 2026, 17:49Malik Ghannam: Recent Venous Thrombosis Risk Factors May Help Explain Cryptogenic Stroke in Young Adults
-
Sep 1, 2026, 17:42Rishabh Jain: Renal Artery FMD Is Managed With Balloon Angioplasty Alone
-
Sep 1, 2026, 17:42Caitlin R: The Brain’s Need to Find Patterns
-
Sep 1, 2026, 17:39José Antonio García Erce: A Modifiable Risk That Demands Attention
-
Sep 1, 2026, 17:39Ryan O’Keefe: Recognizing Warm AIHA From Hemolysis and a Positive DAT
-
Sep 1, 2026, 17:38Anjan Gupta: Catheter-Directed Thrombolysis With Alteplase Lowers Risk in Intermediate-High-Risk PE
-
Sep 1, 2026, 17:35Agnes (Mavis) Kisakye: New Appointment to the WFH HOT Twinning Committee
-
Sep 1, 2026, 17:33Getnet Tarekegn: Comparing Oral Iron Preparations in Pediatric Iron Deficiency Anemia
-
Sep 1, 2026, 17:30Does Platelet FcγRIIA Really Amplify Thrombosis on Its Own? – RPTH Journal